Eikelboom JW, Connolly SJ, Bosch J, et al

Mechanisms of Action Retatrutide activates three key receptors to modulate energy balance, appetite, and metabolism, leading to profound weight loss and glycemic control.[1][2] This triple agonism differentiates it from dual agonists like tirzepatide, enhancing fat oxidation and insulin sensitivity.[3][10] Key sub-mechanisms include: GLP-1 Receptor Activation : Suppresses appetite, delays gastric emptying, and promotes insulin secretion in a glucose-dependent manner.[1][11] GIP Receptor Activation : Enhances insulinotropic effects and improves beta-cell function, contributing to postprandial glucose control.[2][12] Glucagon Receptor Activation : Increases energy expenditure, promotes lipolysis, and supports hepatic fat reduction without significant hyperglycemia.[1][13] Synergistic Metabolic Regulation : Combines receptor effects to amplify weight loss through reduced caloric intake and increased thermogenesis.[3][14] Cardiometabolic Protection : Improves lipid profiles and reduces inflammation via multi-pathway modulation.[4][15] These mechanisms highlight Retatrutide's potential for compounding in therapies targeting obesity and related comorbidities

Consent forms were electronically emailed to potential participants allowing time for review, discussion with loved ones, and ability to have all questions answered prior to signing
C) The AA/glutathione cycle in plants is associated with scavenging of peroxide, superoxide, and hydroxyl radical, and is hypothesized to reduce nsHbs in support of NOD
Gentle application, reliable results Subcutaneous delivery uses smaller needles, making each dose quicker and more comfortable than traditional methods